Positron Corporation announced the appointment of Charles Conroy as Chief Operating Officer. Conroy's background includes extensive experience in corporate & product strategy, partner & alliance management, licensing, acquisitions, divestitures and portfolio management. During his career, Conroy has led highly successful global business development, marketing, and operations initiatives for companies including Covidien, Eli Lilly, and Amerinet.

As COO, Conroy will define and implement strategies focused on accelerating growth across the company's product portfolio. Conroy joins Positron's clinical and technical executive team, consisting of: Joseph Oliverio (PET), Jason Kitten (Radiopharmaceutical/Radioisotope Production) and Scott Stiffler (Pharmaceutical Automation/Product Development). Conroy will also lead the Company's sales and marketing initiatives; focusing on revenue generation, enhancing Positron's industry position and brand recognition as a leader in nuclear medicine.